Contribution of NAD(P)H Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and Risk of Colorectal Adenoma and Colorectal Cancer in Caucasians: A Meta-analysis

Archives of Medical Research

Volumn 43, Issue 1, 2012, Pages 58-66

  Chen, Jing ^a   Lin, Yuan ^a   Zhang, Ru ^a   Huang, Zhi jie ^a   Pan, Xing guo ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Colorectal cancer; Colorectal tumor; Meta analysis; NQO1 gene; Polymorphism

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE QUINONE OXIDOREDUCTASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; COLORECTAL ADENOMA; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMBASE; ENZYME POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; META ANALYSIS; RISK; STATISTICAL SIGNIFICANCE;

ADENOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; HUMANS; LINEAR MODELS; MUTATION, MISSENSE; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84859250936     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.01.005     Document Type: Article

References (37)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Zhao P., Dai M., Chen W., et al. Cancer trends in China. Jpn J Clin Oncol 2010, 40:281-285.
3. Itzkowitz S.H. Gastrointestinal adenomatous polyps. Semin Gastrointest Dis 1996, 7:105-116.
4. Northwood E.L., Elliott F., Forman D., et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics 2010, 20:315-326.
5. Landi S., Gemignani F., Moreno V., et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005, 15:535-546.
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52:6735-6740.
7. Qasim A., O'Morain C. Primary prevention of colorectal cancer: are we closer to reality?. Eur J Gastroenterol Hepatol 2010, 22:9-17.
8. Muller H., Plasilova M., Russell A.M., et al. Genetic predisposition as a basis for chemoprevention, surgical and other interventions in colorectal cancer. Recent Results Cancer Res 2003, 163:235-247. discussion 264-266.
9. Brevik A., Joshi A.D., Corral R., et al. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev 2010, 19:3167-3173.
10. Yeh C.C., Sung F.C., Tang R., et al. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Dis Colon Rectum 2009, 52:104-111.
11. Ross D., Kepa J.K., Winski S.L., et al. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000, 129:77-97.
12. Joseph P., Jaiswal A.K. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 1994, 91:8413-8417.
13. Siegel D., McGuinness S.M., Winski S.L., et al. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 1999, 9:113-121.
14. Sameer A.S., Shah Z.A., Syeed N., et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev 2010, 11:209-213.
15. Sachse C., Smith G., Wilkie M.J., et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002, 23:1839-1849.
16. Begleiter A., Hewitt D., Maksymiuk A.W., et al. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:2422-2426.
17. Hamajima N., Matsuo K., Iwata H., et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol 2002, 7:103-108.
18. Harth V., Donat S., Ko Y., et al. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer. Arch Toxicol 2000, 73:528-531.
19. Hlavata I., Vrana D., Smerhovsky Z., et al. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol Rep 2010, 24:1347-1353.
20. Hou L., Chatterjee N., Huang W.Y., et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005, 26:1122-1128.
21. Mitrou P.N., Watson M.A., Loktionov A.S., et al. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis 2007, 28:875-882.
22. Nisa H., Kono S., Yin G., et al. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer 2010, 10:274.
23. Tijhuis M.J., Visker M.H., Aarts J.M., et al. NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopy-based population. Int J Cancer 2008, 122:1842-1848.
24. van der Logt E.M., Bergevoet S.M., Roelofs H.M., et al. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat Res 2006, 593:39-49.
25. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003, 56:297-303.
26. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
27. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
28. Liu L., Zeng F., Wang K., et al. Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol 2011, 137:1027-1036.
29. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
30. Egger M., Davey S.G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
31. Chao C., Zhang Z.F., Berthiller J., et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:979-987.
32. Kopec J.A., Esdaile J.M. Bias in case-control studies. A review. J Epidemiol Community Health 1990, 44:179-186.
33. Yuan W., Xu L., Chen W., et al. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 2011, 125:467-472.
34. Saldivar S.J., Wang Y., Zhao H., et al. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res 2005, 582:71-78.
35. Sarbia M., Bitzer M., Siegel D., et al. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer 2003, 107:381-386.
36. Hu X., Zhang Z., Ma D., et al. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:755-761.
37. Fan W., Maoqing W., Wangyang C., et al. Relationship between the polymorphism of tumor necrosis factor-alpha-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet 2011, 19:432-437.